Cancers (Aug 2022)

Whole-Exome Sequencing Identifies Pathogenic Germline Variants in Patients with Lynch-Like Syndrome

  • Wellington dos Santos,
  • Edilene Santos de Andrade,
  • Felipe Antonio de Oliveira Garcia,
  • Natália Campacci,
  • Cristina da Silva Sábato,
  • Matias Eliseo Melendez,
  • Rui Manuel Reis,
  • Henrique de Campos Reis Galvão,
  • Edenir Inez Palmero

DOI
https://doi.org/10.3390/cancers14174233
Journal volume & issue
Vol. 14, no. 17
p. 4233

Abstract

Read online

Lynch syndrome (LS) is the most common hereditary colorectal cancer (CRC) syndrome, characterized by germline pathogenic variants in mismatch repair (MMR)-related genes that lead to microsatellite instability. Patients who meet the clinical criteria for LS and MMR deficiency and without any identified germline pathogenic variants are frequently considered to have Lynch-like syndrome (LLS). These patients have a higher risk of CRC and extracolonic tumors, and little is known about their underlying genetic causes. We investigated the germline spectrum of LLS patients through whole-exome sequencing (WES). A total of 20 unrelated patients with MMR deficiency who met the clinical criteria for LS and had no germline variant were subjected to germline WES. Variant classification was performed according to the American College of Medical Genetics and Genomics (ACMG) criteria. Pathogenic/likely pathogenic variants were identified in 35% of patients in known cancer genes such as MUTYH and ATM. Besides this, rare and potentially pathogenic variants were identified in the DNA repair gene POLN and other cancer-related genes such as PPARG, CTC1, DCC and ALPK1. Our study demonstrates the germline mutational status of LLS patients, a population at high risk of colorectal cancer.

Keywords